Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821337 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03821337: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT03821337 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03821337, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Despite the availability of opioid replacement therapies, many opioid use disordered Veterans are not able to remain abstinent. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique with a consistent, rapidly expanding literature base reporting positive outcomes in substance using populations. This pilot application will investigate a novel multi-session rTMS paradigm to determine feasibility and tolerability of this intervention in opioid use disordered Veterans.
Primary Outcome
Total number of rTMS sessions completed out of 6 sessions per day for three days over a three week period.
Interventions
- DEVICE Sham TMS
- DEVICE repetitive Trans Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Why NCT03821337 stopped before completion
NCT03821337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham TMS is the first listed.
NCT03821337 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03821337 about?
NCT03821337 is a clinical study titled "Transcranial Magnetic Stimulation (rTMS) as a Tool to Decrease Pain and Improve Functioning". Despite the availability of opioid replacement therapies, many opioid use disordered Veterans are not able to remain abstinent. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique with a consistent, rapidly expanding literature base reporting positive outc...
What is the current status of trial NCT03821337?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-10-11. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03821337?
The interventions under investigation include: Sham TMS (DEVICE), repetitive Trans Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03821337?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03821337's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI